Table 6 Characteristics of the 24 DNA diploid and 23 DNA aneuploid breast tumors
Human breast tumors (n = 47) | |||
|---|---|---|---|
DNA diploid breast tumors (n = 24) | DNA aneuploid breast tumors (n = 23) | Pa | |
Age | |||
≤ 05 | 2 (8.3%) | 1 (4.3%) | NS |
> 50 | 22 (91.7%) | 22 (95.7%) | |
SBR histological grade b | |||
I | 9 (37.5%) | 2 (8.7%) | 0.0061 |
II | 12 (50%) | 9 (39.1%) | |
III | 3 (12.5%) | 12 (52.2%) | |
Lymph node status | |||
Negative | 14 (58.3%) | 15 (65.2%) | NS |
Positive | 10 (41.7%) | 8 (34.8%) | |
Macroscopic tumor size | |||
≤ 20 mm | 12 (50%) | 11 (48%) | NS |
> 20 mm | 12 (50%) | 12 (52%) | |
PR status | |||
Negative | 3 (12.5%) | 8 (34.8%) | NS |
Positive | 21 (87.5%) | 15 (65.2%) | |
ER status | |||
Negative | 0 (0%) | 7 (30.4%) | 0.012 |
Positive | 24 (100%) | 16 (69.6%) | |
ERBB2 status | |||
Negative | 19 (79.2%) | 17 (73.9%) | NS |
Positive | 5 (20.8%) | 6 (26.1%) | |
Molecular subtypes | |||
RH- ERBB2- | 0 (0%) | 4 (17.4%) | NS |
RH- ERBB2+ | 0 (0%) | 1 (4.4%) | |
RH+ ERBB2- | 19 (79.2%) | 13 (56.5%) | |
RH+ ERBB2+ | 5 (20.8%) | 5 (21.7%) | |
Histologic types | |||
Ductal | 21 (87.5%) | 23 (100%) | NS |
Lobular | 2 (8.3%) | 0 | |
Tubular | 1 (4.2%) | 0 | |